Avricore Health Inc.

Equities

AVCR

CA0545211090

Pharmaceuticals

Delayed Toronto S.E. 09:30:00 2024-04-23 am EDT 5-day change 1st Jan Change
0.15 CAD 0.00% Intraday chart for Avricore Health Inc. +7.14% -11.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations MT
Avricore Health Provides Update on Q3 MT
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Avricore Health Inc. Expands Its Innovative Point-Of-Care Chronic and Infectious Disease Screening and Health- Data Management Platform, Healthtab CI
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Avricore Health Up Nearly 14% After Reporting Reseller Pact Between HealthTab, Abbott Rapid Dx UK & Ireland MT
Avricore Health Inc. Announces its Agreement with Ascensia Diabetes Care to Integrate Their Blood Glucose Monitoring Systems, Marketed as Contour Next Gen and Four Next One CI
HealthTab to Integrate CONTOUR NEXT Family of Blood Glucose Meters For Deeper Diabetes Patient Insights MT
Avricore Health Inc Announces Agreement with Ascensia Diabetes Cares CI
Avricore Health Inc. Announces Board Changes CI
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Avricore Health Inc. Auditor Raises 'Going Concern' Doubt CI
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Avricore Health's HealthTab Passes 530 Locations, Adds Virus Detection MT
Avricore Health Provides Update MT
Avricore Health Expands the Number of Shoppers Drug Mart Pharmacies Offering Its HealthTab Point-Of-Care Testing Platform Under A Renewed Master Service Agreement CI
Avricore Health Reports Q3 Results MT
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Avricore Health Inc. Expands with Shoppers Drug Mart® CI
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Avricore Health Inc. Auditor Raises 'Going Concern' Doubt CI
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Avricore Health to Offer Abbott Test to Select Community Pharmacies in Canada MT
Chart Avricore Health Inc.
More charts
Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.
More about the company
  1. Stock Market
  2. Equities
  3. AVCR Stock
  4. News Avricore Health Inc.
  5. Avricore Health : Partners with Ellerca Health to Offer Joint Diabetes Screening and Management Support